Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -130.14x as of the fiscal period ended Sunday, June 30, 2024.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-130.14x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-1990.65%
vs the sector median at left
Bio Green Med Solution, Inc.
Market Cap
$4.69M
Interest Coverage Ratio
-130.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.83M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$5.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.10M
Interest Coverage Ratio
-13.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $4.69M | -130.14x | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.65M | -16.26x | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.71M | N/A | N/A | N/A | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.83M | N/A | 1.10x | 1.10x | 1.10x |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -765.53x | 1.76x | 1.76x | 1.76x |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.01M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.13M | N/A | 1.00x | 1.02x | 1.02x |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.10M | -13.75x | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.25M | -21.32x | 128.62x | 128.62x | 128.62x |
Interest Coverage
-130.1x
Debt/Equity
0.00
Current Ratio
8.63
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | -130.14x |
